Mesothelioma Clinical Trials in New York, New York
8 recruitingNew York, New York
Showing 1–8 of 8 trials
Recruiting
Phase 1
A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer
Urothelial CarcinomaDiffuse Pleural MesotheliomaGastroesophageal Carcinoma
Memorial Sloan Kettering Cancer Center60 enrolled7 locationsNCT07532902
Recruiting
Phase 1
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Gastric AdenocarcinomaBladder CancerMesothelioma+7 more
IDEAYA Biosciences260 enrolled10 locationsNCT07277413
Recruiting
Phase 1Phase 2
Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors
NSCLCSolid Tumor, AdultMesothelioma
Vivace Therapeutics, Inc434 enrolled12 locationsNCT04665206
Recruiting
Phase 1
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Mesothelioma
Bristol-Myers Squibb336 enrolled25 locationsNCT05245500
Recruiting
Not Applicable
Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma
Malignant Pleural Mesothelioma
Memorial Sloan Kettering Cancer Center20 enrolled7 locationsNCT06037941
Recruiting
Phase 2
A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma
Malignant MesotheliomaMesotheliomaMesothelioma, Malignant+2 more
Memorial Sloan Kettering Cancer Center64 enrolled13 locationsNCT06057935
Recruiting
Phase 2
A Study of Sacituzumab Govitecan in People With Mesothelioma
MesotheliomaMesotheliomas PleuralMesothelioma; Pleura
Memorial Sloan Kettering Cancer Center33 enrolled7 locationsNCT06477419
Recruiting
Phase 1Phase 2
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Endometrial CancerAdvanced Solid TumorDiffuse Large B Cell Lymphoma+5 more
Novartis Pharmaceuticals275 enrolled60 locationsNCT04104776